Summary
3M Company reported net sales of $7.991 billion for the third quarter of 2019, a slight decrease of 2.0% compared to the same period last year. Net income attributable to 3M was $1.583 billion, or $2.72 per diluted share, representing a 5.4% increase on a per diluted share basis. This growth was primarily driven by benefits from restructuring actions and a lower effective tax rate, which offset weaker sales in key segments like Safety and Industrial and Transportation and Electronics. These segments experienced softness in end markets such as China, automotive, and electronics, compounded by channel inventory adjustments. Despite these headwinds, 3M's Health Care and Consumer segments showed resilience with modest sales growth. Financially, the company ended the quarter with a strong balance sheet, reporting $7.7 billion in cash and cash equivalents. However, total debt increased due to significant debt issuances, primarily in anticipation of the Acelity acquisition. The company continued its commitment to returning capital to shareholders through dividends, increasing its quarterly dividend by 6% to $1.44 per share. 3M is also actively managing its portfolio through divestitures, including the sale of its gas and flame detection business, while investing in strategic acquisitions like M*Modal and planning for future growth initiatives.
Financial Highlights
54 data points| Revenue | $7.99B |
| Cost of Revenue | $4.19B |
| Gross Profit | $3.80B |
| SG&A Expenses | $1.46B |
| Operating Expenses | $5.98B |
| Operating Income | $2.01B |
| Interest Expense | $109.00M |
| Net Income | $1.58B |
| EPS (Basic) | $2.75 |
| EPS (Diluted) | $2.72 |
| Shares Outstanding (Basic) | 576.50M |
| Shares Outstanding (Diluted) | 583.00M |
Key Highlights
- 1Third quarter 2019 net sales were $7.991 billion, down 2.0% year-over-year.
- 2Net income attributable to 3M increased by 5.4% to $1.583 billion, and diluted EPS grew by 5.4% to $2.72.
- 3The Safety and Industrial and Transportation & Electronics segments saw sales declines, impacted by market softness and inventory adjustments.
- 4The Health Care segment reported a 4.7% increase in sales, driven by organic growth and acquisitions, while the Consumer segment saw a modest 1.7% sales increase.
- 53M's operating cash flow for the first nine months of 2019 increased to $4.732 billion.
- 6The company announced a new share repurchase program authorizing up to $10 billion and continued its dividend growth, marking the 61st consecutive year of increases.
- 7Significant litigation-related charges and restructuring actions impacted results, with the company actively managing these costs and their ongoing effects.